Dyadic to present at world vaccine congress washington 2023

Jupiter, fla., march 30, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that its chief executive officer, mark emalfarb will be presenting at the upcoming world vaccine congress in washington, d.c.
DYAI Ratings Summary
DYAI Quant Ranking